Why AngioDynamics, Inc.’s (ANGO) Stock Is Down 16.35%
As of Thursday, October 08, AngioDynamics, Inc.’s ANGO share price has dipped by 16.35%, which has investors questioning if this is right time to buy.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Tudor Pop
Rosalio Madrigal
Michael Rose
Rosalio Madrigal
| Share Statistics | ANGO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $487.0 | $382.4 | 38% |
|
| Shares Out (Mil) | 42.0 | 40.7 | 43% |
|
| Institutional Ownership | 89.1% | 83.2% | 57% |
|
| Float (Mil) | 32.7 | 35.1 | 38% |
|
| Beta | 0.30 | 0.85 | 18% |
|
| Avg Daily Volume (000s) | 1,400 | 296 | 76% |
|
| Price Change (52-week) |
1.5% | 63.9% | 54% |
|
| Growth | ANGO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 1.9% | 11.8% | 23% |
|
| Net Income (5yr) | (3.1%) | (5.5%) | 36% |
|
| EPS (5yr) | (1.5%) | 10.4% | 29 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 20.8% | (15.5%) | 80% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | ($0.073) | ($0.280) | ($0.113) | |
| Month Ago EPS | ($0.083) | ($0.267) | ($0.045) | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.083) | ($0.267) | ($0.045) | |
| Year/Year Chg | (57.1%) | (68.4%) | (124.9%) | |
| Financials | ANGO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $325 | $128 | 36% |
|
| Net Income (TTM) (Mil) | ($33) | ($9) | 20% |
|
| EPS (TTM) | ($0.789) | ($0.400) | 24% |
|
| Operating Cash Flow (TTM) (Mil) | $4 | ($2) | 35% |
|
| Net Cash Flow (TTM) (Mil) | ($5) | $1 | 34% |
|
| Long-Term Debt (Q1) (Mil) | $9 | $26 | 27% |
|
| Enterprise Value (Q1) (Mil) | $456 | $409 | 33% |
|
| Valuation | ANGO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.00 | 2.51 | 67% |
|
| P/E | na | 26.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | ANGO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 55.3% | 59.0% | 68% |
|
| Net Margin | (10.1%) | (6.9%) | 21% |
|
| ROA | (13.0%) | (12.2%) | 23% |
|
| ROE | (19.2%) | (10.7%) | 24% |
|
| Liabilities to Assets | 32.2% | 47.2% | 23% |
|
| F-Score | 5 | 4 | 50% |
|
AngioDynamics, Inc. did not pass any screens on 10/15/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors